Atossa Genetics (NASDQ: ATOS) is a clinical-stage drug company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions.
Visit our YouTube channel to learn more about Atossa Genetics.
Atossa Genetics Receives Positive Interim Safety Review from Independent Safety Committee in Phase 1 Topical Endoxifen Dose Escalation Study in Men
Atossa Genetics To Host Corporate Conference Call Wednesday, May 16, 2018 at 4:30pm EDT
Atossa Genetics Announces First Quarter 2018 Financial Results And Provides Company Update
More Press Releases
Learn more about Atossa Genetics
Learn more about our programs
Contact Atossa Genetics today!